Veriheal

JANUARY 5, 2023

A randomized, double-blind, cross-over trial of cannabis recently published by Research Gate explored whether or not cannabidiol (CBD) — the primary non-intoxicating constituent of cannabis and hemp — improves or reduces the cannabis safety. . About the Study Into CBD’s Influence on Cannabis Safety.

Clinical Trials 82

Clinical Trials Safety Consumption CBD 82

Cannabis Law Report

NOVEMBER 16, 2021

For multiple health and safety reasons, we believe orally dosed MYMD-1 is vastly superior to any of the available TNF inhibitors on the market today, one of which is the best-selling drug in the world.”. The secondary measures will be the safety, tolerability, and pharmacokinetics in this population of patients. Chapman continued.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

OCTOBER 26, 2021

Chapman is a seasoned executive and global medical expert with extensive experience in designing and clinical trial protocols and conducting clinical trials. The Company’s second drug platform, Supera-CBD , is being developed to treat chronic pain, addiction and epilepsy.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

JULY 4, 2021

According to this law, any person possessing cannabis or a cannabis derivative is considered guilty of breaking the law. Clinical trials across the EU have also shown CBD oils and other hemp products to have a potential range of benefits. Some users also claim that CBD helps with chronic pain, insomnia, and anxiety.

THC 105

THC CBD Legalization Oil 105

The Joint Blog

OCTOBER 21, 2020

Since CBD is a hemp product, it is required by law to contain no more than 0.3 Due to the updated hemp act being relatively new, lawmakers are still studying and formulating policies that can better improve the industry while regulating it for the safety of users. Hemp Plant State Laws. Is CBD Legal in the United States?

CBD 36

CBD Legalization Oil Hemp 36

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Essay: “The Nature of Hemp and Law: Hazy Regulation”. Jack Devanna . School: The University of Rhode Island.

Research and Development 117

Research and Development Education Agriculture Patients 117

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

JULY 24, 2019

Examples of claims observed on your website and social media accounts in April 2019 that establish the intended use of your products as drugs include, but may not be limited to, the following: On your product webpage for CBD Disposable Vape Pen (Relieve): • “[F]or chronic pain.”. Chronic or arthritic pain.”. Chronic pain.

CBD 51

CBD Tincture Pets Chronic Pain 51

Cannabis Law Report

DECEMBER 20, 2021

(“Virpax” or the “Company”) (NASDAQ: VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, signed a clinical trial agreement with Altasciences Company, Inc.,

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Data 52

Cannabis Law Report

JUNE 11, 2019

This controversy is evident in the case law reviewed. Given the controversy over the efficacy and safety of cannabis for therapeutic purposes, a key question in these cases, is whether cannabis meets the requirement of medical justification. At the time of trial, she was using marijuana to treat her symptoms. Robichaud 4.

Chronic Pain 45

Chronic Pain Cannabis History Treatment 45

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). This post is dedicated to clearing up some of the confusion behind ketamine clinic set-up and operation.

Therapy 89

Therapy Legalization Chronic Pain DEA 89

Cannabis Law Report

OCTOBER 22, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. VSN16R was shown to be safe and well-tolerated in its Phase I clinical safety trial. Key Questions Answered.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Canna Law Blog

MARCH 4, 2020

Similar to ketamine, psilocybin has shown great promise in clinical trials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). This post is dedicated to clearing up some of the confusion behind ketamine clinic set-up and operation.

Legalization 52

Legalization Therapy Chronic Pain DEA 52

Cannabis Law Report

NOVEMBER 10, 2021

as well as to support Good Laboratory Practices (GLP) toxicology, safety studies and preclinical efficacy studies. The NIH has contracted with a clinical research organization to conduct additional pre-clinical efficacy studies and procured a device to be used with the manufactured GMP drug product for preclinical and clinical studies.

Research and Development 52

Research and Development Chronic Pain Pharmaceutical Clinical Trials 52

Cannabis Law Report

DECEMBER 8, 2021

Charles River Laboratories, a renowned CRO engaged by Virpax to perform Food and Drug Administration (FDA) required pre-clinical studies, has completed a single dose pharmacokinetic study of dermal administration of Epoladerm in minipigs as part of the required Investigational New Drug Application (“IND”) enabling trials.

Clinical Trials 52

Clinical Trials Chronic Pain Pharmaceutical Topical 52

Cannabis Law Report

OCTOBER 18, 2021

The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronic pain, cancer, arthritis, diabetes, depression, anxiety, and many more. VSN16R was shown to be safe and well-tolerated in its Phase I clinical safety trial. INM-755: InMed Pharmaceuticals.

Research and Development 52

Research and Development Pharmaceutical Chronic Pain Therapy 52

Cannabis Law Report

DECEMBER 28, 2021

Upon completion of all the required IND enabling studies and subsequent review by the FDA, Virpax intends to conduct a Phase 1 study to evaluate the relative bioavailability and pharmacokinetics of Epoladerm™ Virpax recently announced the execution of a clinical trial agreement with Altasciences Company, Inc.,

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Chronic Pain 52

The Cannigma

MARCH 12, 2021

We’re not going to get over the fact that there’s not the same sort of clinical trial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. And in my belief, it should be cannabis, because of the safety profile, number one.

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Before 2016, Australian law considered cannabis an illegal drug. A recent study by Lintzeris et al.

Research and Development 52

Research and Development Medicine Access Media 52

The Cannigma

APRIL 8, 2021

Any other medication and you’re lawfully entitled to speak to a pharmacist,” explains Dr. Codi Peterson, a clinical pharmacist and medical cannabis professional. The law states, you must be ensured the opportunity to speak with someone like me.” . The law states, you must be ensured the opportunity to speak with someone like me.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

MAY 13, 2019

“There’s still a lot we don’t know about medicinal cannabis … when it comes to the pharmacology, what does it do on a molecular level and how does it affect things like chronic pain or symptoms of MS [multiple sclerosis]?”. More recent studies have demonstrated, however, a plausible rationale for therapeutic action.[

Medicine 45

Medicine Research and Development Clinical Trials Data 45

Cannabis Law Report

AUGUST 30, 2019

The National Institute on Drug Abuse published a grant notice to encourage research on the effects of changing US cannabis laws and policies on public health. The Department is opposing the bill on grounds that it will create significant problems by bringing the state into conflict with federal laws designed to prevent money laundering.

Banking 45

Banking Research and Development Legislation Programs 45

Cannabis Law Report

OCTOBER 20, 2021

Law 360 (sub. s NORML Coordinator Dale Gieringer, Delta-8 has undergone minimal testing in humans, “therefore, little is known about its long-term safety, its consumption at high dosages, or its medicinal effects.” Additionally, the advocacy group views Delta-8 THC as a Schedule I substance under federal law. Law 360 (sub.

Hemp 52

Hemp Clinical Trials CBD Legalization 52

Weedistry

FEBRUARY 4, 2019

Currently, 33 states along with the District of Columbia, Guam and Puerto Rico have passed laws for comprehensive medical cannabis programs — but critics often point out we’re lacking definitive proof that marijuana safely and effectively treats many of the qualifying conditions. doesn’t mean it doesn’t work.

Clinical Trials 40

Clinical Trials Pharmaceutical Chronic Pain Safety 40

Cannabis Law Report

OCTOBER 17, 2019

Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. how the segments are defined (e.g.,

Law 40

Law Seed-To-Sale Hemp Recreational 40

NORML

JANUARY 28, 2019

The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinical trials, finding evidence for cannabis as medicine. If the state Senate won’t get behind rescheduling cannabis, they are effectively asking to see research that can’t be conducted under federal law.

Data 189

Data Clinical Trials Chronic Pain Medicine 189